EXOR NV (EXO.AS) Stock Fundamental Analysis

AMS:EXO • NL0012059018

71.05 EUR
-1.25 (-1.73%)
Last: Mar 3, 2026, 05:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

Taking everything into account, EXO scores 4 out of 10 in our fundamental rating. EXO was compared to 55 industry peers in the Financial Services industry. No worries on liquidiy or solvency for EXO as it has an excellent financial health rating, but there are worries on the profitability. EXO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year EXO has reported negative net income.
  • In the past year EXO had a positive cash flow from operations.
  • Of the past 5 years EXO 4 years were profitable.
  • Each year in the past 5 years EXO had a positive operating cash flow.
EXO.AS Yearly Net Income VS EBIT VS OCF VS FCFEXO.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.62%, EXO is doing worse than 76.36% of the companies in the same industry.
  • The Return On Equity of EXO (-1.78%) is worse than 67.27% of its industry peers.
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROIC N/A
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
EXO.AS Yearly ROA, ROE, ROICEXO.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • In the last couple of years the Profit Margin of EXO has grown nicely.
  • EXO's Operating Margin has improved in the last couple of years.
  • EXO has a worse Gross Margin (-5096.69%) than 65.45% of its industry peers.
  • In the last couple of years the Gross Margin of EXO has grown nicely.
  • The Profit Margin and Operating Margin are not available for EXO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -5096.69%
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
EXO.AS Yearly Profit, Operating, Gross MarginsEXO.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • EXO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, EXO has less shares outstanding
  • Compared to 5 years ago, EXO has less shares outstanding
  • The debt/assets ratio for EXO has been reduced compared to a year ago.
EXO.AS Yearly Shares OutstandingEXO.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
EXO.AS Yearly Total Debt VS Total AssetsEXO.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

  • EXO has an Altman-Z score of 3.78. This indicates that EXO is financially healthy and has little risk of bankruptcy at the moment.
  • EXO has a better Altman-Z score (3.78) than 87.27% of its industry peers.
  • EXO has a debt to FCF ratio of 1.25. This is a very positive value and a sign of high solvency as it would only need 1.25 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.25, EXO belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
  • A Debt/Equity ratio of 0.08 indicates that EXO is not too dependend on debt financing.
  • EXO's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. EXO outperforms 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Altman-Z 3.78
ROIC/WACCN/A
WACC4.56%
EXO.AS Yearly LT Debt VS Equity VS FCFEXO.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • EXO has a Current Ratio of 2.21. This indicates that EXO is financially healthy and has no problem in meeting its short term obligations.
  • EXO has a better Current ratio (2.21) than 76.36% of its industry peers.
  • A Quick Ratio of 2.21 indicates that EXO has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.21, EXO is in the better half of the industry, outperforming 76.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.21
Quick Ratio 2.21
EXO.AS Yearly Current Assets VS Current LiabilitesEXO.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • EXO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -104.11%.
  • EXO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.47% yearly.
  • EXO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.78%.
  • EXO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.03% yearly.
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%

3.2 Future

  • EXO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -56.74% yearly.
  • The Revenue is expected to decrease by -93.05% on average over the next years. This is quite bad
EPS Next Y-122.68%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EPS Next 5YN/A
Revenue Next Year-99.97%
Revenue Next 2Y-98.17%
Revenue Next 3Y-93.05%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXO.AS Yearly Revenue VS EstimatesEXO.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50B 100B 150B
EXO.AS Yearly EPS VS EstimatesEXO.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • EXO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 36.45, the valuation of EXO can be described as expensive.
  • Based on the Price/Forward Earnings ratio, EXO is valued a bit more expensive than 69.09% of the companies in the same industry.
  • EXO's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 24.95.
Industry RankSector Rank
PE N/A
Fwd PE 36.45
EXO.AS Price Earnings VS Forward Price EarningsEXO.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXO indicates a rather cheap valuation: EXO is cheaper than 89.09% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 5.25
EV/EBITDA N/A
EXO.AS Per share dataEXO.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • EXO's earnings are expected to decrease with -56.74% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. Dividend

5.1 Amount

  • EXO has a yearly dividend return of 0.65%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.26, EXO has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.82, EXO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

  • The dividend of EXO decreases each year by -47.20%.
Dividend Growth(5Y)-47.2%
Div Incr Years2
Div Non Decr Years2
EXO.AS Yearly Dividends per shareEXO.AS Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of EXO are negative and hence is the payout ratio. EXO will probably not be able to sustain this dividend level.
  • EXO's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP-14.35%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EXO.AS Yearly Income VS Free CF VS DividendEXO.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

EXOR NV

AMS:EXO (3/3/2026, 5:36:15 PM)

71.05

-1.25 (-1.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)09-17
Earnings (Next)03-23
Inst Owners28.28%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap14.76B
Revenue(TTM)-302.00M
Net Income(TTM)-648.00M
Analysts86.15
Price Target116.28 (63.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend0.46
Dividend Growth(5Y)-47.2%
DP-14.35%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.98%
PT rev (3m)-1.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-99.97%
Revenue NY rev (3m)-99.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.45
P/S N/A
P/FCF 5.25
P/OCF 5.25
P/B 0.41
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)-3.12
EYN/A
EPS(NY)1.95
Fwd EY2.74%
FCF(TTM)13.53
FCFY19.05%
OCF(TTM)13.53
OCFY19.05%
SpS-1.45
BVpS174.97
TBVpS174.97
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.62%
ROE -1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -5096.69%
FCFM -931.13%
ROA(3y)14.68%
ROA(5y)9.18%
ROE(3y)25.64%
ROE(5y)17.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.23%
ROCE(5y)12.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y119.43%
OM growth 5Y70.93%
PM growth 3Y165.23%
PM growth 5Y113.99%
GM growth 3Y61.62%
GM growth 5Y43.9%
F-Score5
Asset Turnover-0.01
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.25
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.21
Quick Ratio 2.21
Altman-Z 3.78
F-Score5
WACC4.56%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)46.89%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-104.11%
EPS 3Y104.89%
EPS 5Y38.47%
EPS Q2Q%-104.49%
EPS Next Y-122.68%
EPS Next 2Y-76.12%
EPS Next 3Y-56.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-100.78%
Revenue growth 3Y-22.92%
Revenue growth 5Y-36.03%
Sales Q2Q%-103.68%
Revenue Next Year-99.97%
Revenue Next 2Y-98.17%
Revenue Next 3Y-93.05%
Revenue Next 5YN/A
EBIT growth 1Y-102.73%
EBIT growth 3Y69.13%
EBIT growth 5Y9.34%
EBIT Next Year-105.3%
EBIT Next 3Y-27.17%
EBIT Next 5YN/A
FCF growth 1Y-14.71%
FCF growth 3Y-69.35%
FCF growth 5Y-53.45%
OCF growth 1Y-52.81%
OCF growth 3Y-76.44%
OCF growth 5Y-67.23%

EXOR NV / EXO.AS FAQ

What is the ChartMill fundamental rating of EXOR NV (EXO.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to EXO.AS.


What is the valuation status of EXOR NV (EXO.AS) stock?

ChartMill assigns a valuation rating of 2 / 10 to EXOR NV (EXO.AS). This can be considered as Overvalued.


What is the profitability of EXO stock?

EXOR NV (EXO.AS) has a profitability rating of 3 / 10.


Can you provide the financial health for EXO stock?

The financial health rating of EXOR NV (EXO.AS) is 9 / 10.